CN Patent
CN102573485A — 三嗪衍生物及其治疗应用
Assigned to Abraxis Bioscience LLC · Expires 2012-07-11 · 14y expired
What this patent protects
本发明尤其包含示于式(I)的化合物或其药学上可接受的盐。
USPTO Abstract
本发明尤其包含示于式(I)的化合物或其药学上可接受的盐。
Drugs covered by this patent
- Voranigo (VORASIDENIB) · Servier
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.